Relation Between Wound Complication and Lymphocele After Kidney Transplantation: A Monocentric Study

Transplant Proc. 2020 Jun;52(5):1562-1565. doi: 10.1016/j.transproceed.2020.02.053. Epub 2020 Apr 14.

Abstract

Introduction: Wound complication frequently arises after kidney transplantation and its risk factors are well known. In a previous paper we analyzed these factors, and in this new retrospective study we evaluate the influence of lymphocele in the development of wound complications.

Patients and methods: From January 2000 to December 2018, 731 consecutive kidney transplants have been performed in our center. We have analyzed the incidence of wound complication and lymphocele and their risk factors.

Results: Out of 731 kidney transplants, we have observed wound complications in 115 patients (15.7%) and lymphocele in 158 patients (21.7%). Of these, 70 patients developed both complications (9.5%), but 6 patients have been excluded because they were in therapy with mammalian target of rapamycin inhibitors. Twenty-nine patients (45.3%) presented a first level and 35 patients (54.7%) showed second level wound complications. Lymphocele was the only present factor in just 3 cases (4.6%). The other patients showed diabetes in 28 cases (43.7%), overweight/obesity in 38 (59.3%), delayed graft function in 17 (26.5%), and 60 years or more in 38 (57.8%). The association has been found in 30 out 64 patients treated with tacrolimus (46.8%) and in 34 with cyclosporine (53.1%); 40 patients did not receive muscular layer's reconstruction (62.5%).

Conclusion: Our experience shows that lymphocele alone is not a predisposing factor for wound dehiscence after kidney transplantation, and they often coexist because they share the same risk factors, the most important being obesity, diabetes and delayed graft function, older age, and surgical techniques. No relation has been observed with calcineurin inhibitor therapy.

MeSH terms

  • Adult
  • Aged
  • Cyclosporine / therapeutic use
  • Delayed Graft Function / complications*
  • Diabetes Complications / complications
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Incidence
  • Kidney Transplantation / adverse effects*
  • Lymphocele / complications*
  • Male
  • Middle Aged
  • Obesity / complications
  • Retrospective Studies
  • Risk Factors
  • Sirolimus / therapeutic use
  • Surgical Wound Dehiscence / epidemiology*
  • Tacrolimus / therapeutic use

Substances

  • Immunosuppressive Agents
  • Cyclosporine
  • Sirolimus
  • Tacrolimus